HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Loss of diphthamide pre-activates NF-κB and death receptor pathways and renders MCF7 cells hypersensitive to tumor necrosis factor.

Abstract
The diphthamide on human eukaryotic translation elongation factor 2 (eEF2) is the target of ADP ribosylating diphtheria toxin (DT) and Pseudomonas exotoxin A (PE). This modification is synthesized by seven dipthamide biosynthesis proteins (DPH1-DPH7) and is conserved among eukaryotes and archaea. We generated MCF7 breast cancer cell line-derived DPH gene knockout (ko) cells to assess the impact of complete or partial inactivation on diphthamide synthesis and toxin sensitivity, and to address the biological consequence of diphthamide deficiency. Cells with heterozygous gene inactivation still contained predominantly diphthamide-modified eEF2 and were as sensitive to PE and DT as parent cells. Thus, DPH gene copy number reduction does not affect overall diphthamide synthesis and toxin sensitivity. Complete inactivation of DPH1, DPH2, DPH4, and DPH5 generated viable cells without diphthamide. DPH1ko, DPH2ko, and DPH4ko harbored unmodified eEF2 and DPH5ko ACP- (diphthine-precursor) modified eEF2. Loss of diphthamide prevented ADP ribosylation of eEF2, rendered cells resistant to PE and DT, but does not affect sensitivity toward other protein synthesis inhibitors, such as saporin or cycloheximide. Surprisingly, cells without diphthamide (independent of which the DPH gene compromised) were presensitized toward nuclear factor of kappa light polypeptide gene enhancer in B cells (NF-κB) and death-receptor pathways without crossing lethal thresholds. In consequence, loss of diphthamide rendered cells hypersensitive toward TNF-mediated apoptosis. This finding suggests a role of diphthamide in modulating NF-κB, death receptor, or apoptosis pathways.
AuthorsSebastian Stahl, Ana Rita da Silva Mateus Seidl, Axel Ducret, Sabine Kux van Geijtenbeek, Sven Michel, Tomas Racek, Fabian Birzele, Alexander K Haas, Ruediger Rueger, Michael Gerg, Gerhard Niederfellner, Ira Pastan, Ulrich Brinkmann
JournalProceedings of the National Academy of Sciences of the United States of America (Proc Natl Acad Sci U S A) Vol. 112 Issue 34 Pg. 10732-7 (Aug 25 2015) ISSN: 1091-6490 [Electronic] United States
PMID26261303 (Publication Type: Journal Article, Research Support, N.I.H., Intramural, Research Support, Non-U.S. Gov't)
Chemical References
  • Bacterial Proteins
  • Diphtheria Toxin
  • NF-kappa B
  • Neoplasm Proteins
  • Peptide Elongation Factor 2
  • Receptors, Death Domain
  • pseudomonas exoprotein A protein, Pseudomonas aeruginosa
  • Histidine
  • diphthamide
  • Carbon-Nitrogen Ligases
Topics
  • Apoptosis (drug effects, genetics, physiology)
  • Bacterial Proteins (pharmacology)
  • Breast Neoplasms (pathology)
  • Carbon-Nitrogen Ligases (deficiency, physiology)
  • Cell Line, Tumor
  • Diphtheria Toxin (pharmacology)
  • Female
  • Gene Dosage
  • Gene Knockout Techniques
  • Histidine (analogs & derivatives, biosynthesis, deficiency)
  • Humans
  • NF-kappa B (physiology)
  • Neoplasm Proteins (physiology)
  • Peptide Elongation Factor 2 (chemistry)
  • Protein Processing, Post-Translational
  • Receptors, Death Domain (physiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: